Quantbot Technologies LP Voyager Therapeutics, Inc. Transaction History

Quantbot Technologies LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$7.15 - $10.84 $10,725 - $16,260	1,500 New	1,500 $13,000
Q4 2021 Feb 11, 2022	SELL	$2.47 - $5.55 $9,013 - $20,251	-3,649 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.63 - $4.12 $1,052 - $1,648	-400 Reduced 9.88%	3,649 $9,000
Q2 2021 Aug 12, 2021	SELL	$3.94 - $5.44 $43,363 - $59,872	-11,006 Reduced 73.11%	4,049 $16,000
Q1 2021 May 14, 2021	BUY	$4.61 - $9.04 $69,403 - $136,097	15,055 New	15,055 $70,000
Q4 2019 Feb 10, 2020	SELL	$12.82 - $16.85 $55,061 - $72,370	-4,295 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$16.31 - $28.29 $70,051 - $121,505	4,295 New	4,295 $73,000
Q3 2018 Nov 13, 2018	SELL	$17.11 - $21.74 $121,395 - $154,245	-7,095 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$16.76 - $23.92 $76,241 - $108,812	4,549 Added 178.67%	7,095 $138,000
Q1 2018 May 11, 2018	SELL	$16.16 - $31.31 $19,828 - $38,417	-1,227 Reduced 32.52%	2,546 $47,000
Q4 2017 Feb 12, 2018	BUY	$12.26 - $25.88 $46,256 - $97,645	3,773	3,773 $62,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.